Terms: = Prostate cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Treatment
11953 results:
1. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
[TBL] [Abstract] [Full Text] [Related]
2. Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
[TBL] [Abstract] [Full Text] [Related]
3. treatment of Osteoporosis in Men on Androgen Deprivation Therapy in Japan.
Nishimoto H; Inui A; Mifune Y; Yamaura K; Bando Y; Okamura Y; Hara T; Terakawa T; Kuroda R
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674197
[No Abstract] [Full Text] [Related]
4. Regulation of Molecular Biomarkers Associated with the Progression of prostate cancer.
Martin-Caraballo M
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673756
[TBL] [Abstract] [Full Text] [Related]
5. Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study.
Jahnen M; Amiel T; Kirchoff F; Büchler JW; Herkommer K; Rothe K; Meissner VH; Gschwend JE; Lunger L
World J Urol; 2024 Apr; 42(1):260. PubMed ID: 38664275
[TBL] [Abstract] [Full Text] [Related]
6. Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [
Arbuznikova D; Klotsotyra A; Uhlmann L; Domogalla LC; Steinacker N; Mix M; Niedermann G; Spohn SKB; Freitag MT; Grosu AL; Meyer PT; Gratzke C; Eder M; Zamboglou C; Eder AC
Theranostics; 2024; 14(6):2560-2572. PubMed ID: 38646643
[TBL] [Abstract] [Full Text] [Related]
7. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
[No Abstract] [Full Text] [Related]
8. Surgical management of rectal cancer with synchronous treatment of prostate cancer.
Brière R; Martin AG; Letarte F; Fournier FR; Bouchard P; Drolet S
Langenbecks Arch Surg; 2024 Apr; 409(1):133. PubMed ID: 38642125
[TBL] [Abstract] [Full Text] [Related]
9. Patterns of Care for Medicare Beneficiaries With Metastatic prostate cancer.
Filson CP; Richards TB; Ekwueme DU; Howard DH
Urol Pract; 2024 May; 11(3):489-497. PubMed ID: 38640419
[TBL] [Abstract] [Full Text] [Related]
10. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
[TBL] [Abstract] [Full Text] [Related]
11. Role of oxygen reserve index monitoring in patients undergoing robot-assisted radical prostatectomy: a retrospective study.
Ryu JH; Jeon YT; Sim KM; Lee S; Oh AY; Koo CH
World J Urol; 2024 Apr; 42(1):232. PubMed ID: 38613597
[TBL] [Abstract] [Full Text] [Related]
12. Predictors of postoperative storage symptoms in male patients with lower urinary tract symptoms: A retrospective analysis of prostate surgery for benign prostatic enlargement.
Ito H; Takanashi M; Fukazawa T; Takizawa H; Hioki M; Shinoki R; Kawahara T; Makiyama K; Kobayashi K
Low Urin Tract Symptoms; 2024 May; 16(3):e12512. PubMed ID: 38602061
[TBL] [Abstract] [Full Text] [Related]
13. Clinical safety and efficacy of microwave ablation for small renal masses.
Foret A; Haaga CB; Jain S; Baumgartner CO; Escott M; Henderson BR; O'Brien ST; Delacroix SE; Gills JRR; Westerman ME
Int Braz J Urol; 2024; 50(3):277-286. PubMed ID: 38598830
[TBL] [Abstract] [Full Text] [Related]
14. Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide.
Baser O; Samayoa G; Dwivedi A; AlSaleh S; Cigdem B; Kizilkaya E
Acta Oncol; 2024 Apr; 63():137-146. PubMed ID: 38591349
[TBL] [Abstract] [Full Text] [Related]
15. Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancer.
Wheeler PA; West NS; Powis R; Maggs R; Chu M; Pearson RA; Willis N; Kurec B; Reed KL; Lewis DG; Staffurth J; Spezi E; Millin AE
Radiat Oncol; 2024 Apr; 19(1):45. PubMed ID: 38589961
[TBL] [Abstract] [Full Text] [Related]
16. Androgen deprivation alone versus combined with pelvic radiation for adverse events and quality of life in clinically node-positive prostate cancer.
Lee TH; Pyo H; Yoo GS; Kim JH; Jeon SS; Seo SI; Jeong BC; Jeon HG; Sung HH; Kang M; Song W; Chung JH; Park W
Sci Rep; 2024 Apr; 14(1):8207. PubMed ID: 38589463
[TBL] [Abstract] [Full Text] [Related]
17. The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service.
Lim AR; Park W; Moon SJ; Kim MS; Lee S
BMC Health Serv Res; 2024 Apr; 24(1):412. PubMed ID: 38566103
[TBL] [Abstract] [Full Text] [Related]
18. A preliminary, quantitative study on the use of traditional and complementary medicine by cancer patients seen at the Senkatana oncology clinic, Maseru, Lesotho.
Sooro MA; Thoahlane TS; Ramathebane MV; Mputsoe KA
BMC Complement Med Ther; 2024 Apr; 24(1):136. PubMed ID: 38561693
[TBL] [Abstract] [Full Text] [Related]
19. Development of risk-score model in patients with negative surgical margin after robot-assisted radical prostatectomy.
Yamada Y; Fujii Y; Kakutani S; Kimura N; Sugimoto K; Hakozaki Y; Sugihara T; Takeshima Y; Kawai T; Nakamura M; Kamei J; Taguchi S; Akiyama Y; Sato Y; Yamada D; Urabe F; Miyazaki H; Enomoto Y; Fukuhara H; Nakagawa T; Fujimura T; Kume H
Sci Rep; 2024 Mar; 14(1):7607. PubMed ID: 38556562
[TBL] [Abstract] [Full Text] [Related]
20. The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective.
Yanada BA; Homewood D; Dias BH; Ogluszko C; Corcoran NM
Urol Oncol; 2024 Jun; 42(6):175.e9-175.e18. PubMed ID: 38555235
[TBL] [Abstract] [Full Text] [Related]
[Next]
